Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?
Author:
Publisher
BMJ
Subject
Cardiology and Cardiovascular Medicine
Reference50 articles.
1. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention;Terkelsen;JAMA,2010
2. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology;Hausenloy;Cardiovasc Res,2013
3. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study;Lønborg;Eur Heart J Cardiovasc Imaging,2013
4. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction;Eitel;J Am Coll Cardiol,2014
5. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning;Zhao;Am J Physiol Heart Circ Physiol,2003
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ischemic Postconditioning Confers No Benefit to Left Ventricular Systolic Function: A Meta-Analysis of Cardiac Magnetic Resonance Imaging Results;The American Journal of Cardiology;2023-12
2. Ribosome biogenesis in disease: new players and therapeutic targets;Signal Transduction and Targeted Therapy;2023-01-09
3. Comparison of Effect of Ischemic Postconditioning on Cardiovascular Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention With Versus Without Thrombectomy;The American Journal of Cardiology;2022-03
4. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls;Mechanisms of Ageing and Development;2021-09
5. Tripartite motif-containing protein 16 protects against myocardial ischemia/reperfusion injury by affecting the Keap1/Nrf2 axis;Cell and Tissue Research;2021-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3